Interpretation of effect estimates in competing risks survival models: A simulated analysis of organ-specific progression-free survival in a randomised phase III cancer trial
In survival analyses, competing risks are encountered where the subjects under study are at risk for more than one mutually exclusive failure event [1]. Competing risks are often analysed using either cause-specific or subdistribution (cumulative incidence) proportional hazards models. Cause-specifi...
| Κύριοι συγγραφείς: | , , , , , |
|---|---|
| Μορφή: | Conference item |
| Έκδοση: |
International Society of Clinical Biostatistics
2016
|